Search Results - "JIMENEZ, Wladimiro"

Refine Results
  1. 1

    Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short‐term risk of severe sepsis, hepatorenal syndrome, and death by Acevedo, Juan, Fernández, Javier, Prado, Verónica, Silva, Anibal, Castro, Miriam, Pavesi, Marco, Roca, Daria, Jimenez, Wladimiro, Ginès, Pere, Arroyo, Vicente

    Published in Hepatology (Baltimore, Md.) (01-11-2013)
    “…The prevalence of relative adrenal insufficiency (RAI) in critically ill cirrhosis patients with severe sepsis is over 60% and associated features include poor…”
    Get full text
    Journal Article
  2. 2

    Apelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells by Melgar-Lesmes, Pedro, Casals, Gregori, Pauta, Montserrat, Ros, Josefa, Reichenbach, Vedrana, Bataller, Ramon, Morales-Ruiz, Manuel, Jimenez, Wladimiro

    Published in Endocrinology (Philadelphia) (01-11-2010)
    “…Apelin is a peptide with relevant functions in angiogenesis and inflammation. Recent studies have demonstrated that apelin is overexpressed in hepatic stellate…”
    Get full text
    Journal Article
  3. 3

    Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases by Perramón, Meritxell, Jiménez, Wladimiro

    “…The management of chronic liver diseases (CLDs) remains a challenge, and identifying effective treatments is a major unmet medical need. In the current review…”
    Get full text
    Journal Article
  4. 4

    Graphene–Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy by Melgar-Lesmes, Pedro, Luquero, Aureli, Parra-Robert, Marina, Mora, Adriana, Ribera, Jordi, Edelman, Elazer R, Jiménez, Wladimiro

    Published in Nano letters (12-09-2018)
    “…Fibrosis contributes to ∼45% of all deaths in industrialized nations, but no direct antifibrotic therapeutic interventions exist to date. Graphene-based…”
    Get full text
    Journal Article
  5. 5

    Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia by Ribera, Jordi, Vilches, Clara, Sanz, Vanesa, de Miguel, Ignacio, Portolés, Irene, Córdoba-Jover, Bernat, Prat, Esther, Nunes, Virginia, Jiménez, Wladimiro, Quidant, Romain, Morales-Ruiz, Manuel

    Published in ACS nano (27-04-2021)
    “…Liver fibrosis is a major health problem with multiple associated complications, which, to date, has no effective treatment. Hepatic stellate cells are the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis by Ariza, Xavier, Solà, Elsa, Elia, Chiara, Barreto, Rogelio, Moreira, Rebeca, Morales-Ruiz, Manuel, Graupera, Isabel, Rodríguez, Ezequiel, Huelin, Patricia, Solé, Cristina, Fernández, Javier, Jiménez, Wladimiro, Arroyo, Vicente, Ginès, Pere

    Published in PloS one (04-06-2015)
    “…Biomarkers are potentially useful in assessment of outcomes in patients with cirrhosis, but information is very limited. Given the large number of biomarkers,…”
    Get full text
    Journal Article
  8. 8

    Monocyte-endothelial cell interactions in vascular and tissue remodeling by Medrano-Bosch, Mireia, Simón-Codina, Blanca, Jiménez, Wladimiro, Edelman, Elazer R, Melgar-Lesmes, Pedro

    Published in Frontiers in immunology (07-07-2023)
    “…Monocytes are circulating leukocytes of innate immunity derived from the bone marrow that interact with endothelial cells under physiological or…”
    Get full text
    Journal Article
  9. 9

    Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration by Casals, Eudald, Zeng, Muling, Parra‐Robert, Marina, Fernández‐Varo, Guillermo, Morales‐Ruiz, Manuel, Jiménez, Wladimiro, Puntes, Víctor, Casals, Gregori

    “…Antioxidant nanoparticles have recently gained tremendous attention for their enormous potential in biomedicine. However, discrepant reports of either medical…”
    Get full text
    Journal Article
  10. 10

    Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis by Solé, Cristina, Solà, Elsa, Morales-Ruiz, Manuel, Fernàndez, Guerau, Huelin, Patricia, Graupera, Isabel, Moreira, Rebeca, de Prada, Gloria, Ariza, Xavier, Pose, Elisa, Fabrellas, Núria, Kalko, Susana G., Jiménez, Wladimiro, Ginès, Pere

    Published in Scientific reports (31-08-2016)
    “…ACLF is characterized by a systemic inflammatory response, but the cytokines involved in this process have not been well studied. The aim of this study was to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis by Melgar-Lesmes, Pedro, Perramon, Meritxell, Jiménez, Wladimiro

    Published in Cells (Basel, Switzerland) (24-10-2019)
    “…Hepatic fibrosis is the consequence of an unresolved wound healing process in response to chronic liver injury and involves multiple cell types and molecular…”
    Get full text
    Journal Article
  14. 14

    Partial vasopressin 1a receptor agonism reduces portal hypertension and hyperaldosteronism and induces a powerful diuretic and natriuretic effect in rats with cirrhosis and ascites by Fernández-Varo, Guillermo, Jiménez, Wladimiro, Cable, Edward, Ginès, Pere, Harris, Geoff, Bukofzer, Stan

    Published in Biomedicine & pharmacotherapy (01-09-2023)
    “…The vasopressin system has emerged as a therapeutic focus for lowering portal hypertension and reducing splanchnic vasodilation in patients with refractory…”
    Get full text
    Journal Article
  15. 15

    The Role of Akt in Chronic Liver Disease and Liver Regeneration by Morales-Ruiz, Manuel, Santel, Ansgar, Ribera, Jordi, Jiménez, Wladimiro

    Published in Seminars in liver disease (01-02-2017)
    “…The liver is continuously exposed to diverse insults, which may culminate in pathological processes causing liver disease. An effective therapeutic strategy…”
    Get more information
    Journal Article
  16. 16

    Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients by Soto, Marcelo, Sampietro-Colom, Laura, Lasalvia, Luis, Mira, Aurea, Jiménez, Wladimiro, Navasa, Miquel

    Published in World journal of gastroenterology : WJG (07-05-2017)
    “…AIM To assess liver fibrosis(LF) in hepatitis C virus(HCV) and alcoholic liver disease(ALD), estimate health outcomes and costs of new noninvasive testing…”
    Get full text
    Journal Article
  17. 17

    RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration by Moreno-Lanceta, Alazne, Medrano-Bosch, Mireia, Fundora, Yilliam, Perramón, Meritxell, Aspas, Jessica, Parra-Robert, Marina, Baena, Sheila, Fondevila, Constantino, Edelman, Elazer R, Jiménez, Wladimiro, Melgar-Lesmes, Pedro

    Published in Science translational medicine (12-07-2023)
    “…Hepatic inflammation is a common trigger of chronic liver disease. Macrophage activation is a predictive parameter for survival in patients with cirrhosis…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide by Casals, Eudald, Gusta, Muriel F, Piella, Jordi, Casals, Gregori, Jiménez, Wladimiro, Puntes, Victor

    Published in Frontiers in immunology (14-08-2017)
    “…We review the apparent discrepancies between studies that report anti-inflammatory effects of cerium oxide nanoparticles (CeO NPs) through their reactive…”
    Get full text
    Journal Article
  20. 20

    ARFI, FibroScan®, ELF, and their combinations in the assessment of liver fibrosis: A prospective study by Crespo, Gonzalo, Fernández-Varo, Guillermo, Mariño, Zoe, Casals, Gregori, Miquel, Rosa, Martínez, Stella M, Gilabert, Rosa, Forns, Xavier, Jiménez, Wladimiro, Navasa, Miquel

    Published in Journal of hepatology (01-08-2012)
    “…Background & Aims Our aim was to evaluate a serologic marker (ELF) and two ultrasound-based methods (FibroScan® and ARFI), as well as their combinations, in…”
    Get full text
    Journal Article